Skip to Main Content
Beta test
our new site.
(
NLM Technical Bulletin
)
Home
Search
Study Topics
Glossary
Full Text View
Tabular View
No Study Results Posted
Related Studies
Antimalarial Drug Resistance in Mali
This study has been completed.
Study NCT00127998 Information provided by Centers for Disease Control and Prevention
First Received on July 7, 2005. Last Updated on August 15, 2006
History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Malaria
More general conditions related to this trial
Parasitic Diseases
Protozoan Infections
Interventions listed in this trial
chloroquine
sulfadoxine-pyrimethamine
amodiaquine
amodiaquine+artesunate
artemether-lumefantrine
mefloquine
Additional drug interventions recognized in this trial
Antimalarials
Artemether
Artemether-lumefantrine combination
Artemisinins
Artesunate
Chloroquine diphosphate
Lumefantrine
Pyrimethamine
Sulfadoxine
More general drug interventions related to this trial
Amebicides
Analgesics
Analgesics, Non-Narcotic
Anthelmintics
Anti-Infective Agents
Anti-Infective Agents, Urinary
Anti-Inflammatory Agents
Anti-Inflammatory Agents, Non-Steroidal
Antifungal Agents
Antinematodal Agents
Antiparasitic Agents
Antiplatyhelmintic Agents
Antiprotozoal Agents
Antirheumatic Agents
Central Nervous System Agents
Coccidiostats
Enzyme Inhibitors
Filaricides
Folic Acid Antagonists
Molecular Mechanisms of Pharmacological Action
Peripheral Nervous System Agents
Pharmacologic Actions
Physiological Effects of Drugs
Renal Agents
Schistosomicides
Sensory System Agents
Therapeutic Uses
Sponsors listed in this trial
Centers for Disease Control and Prevention
Malaria Research and Training Center, Bamako
Back to top of Main Content
